154
Participants
Start Date
April 1, 2025
Primary Completion Date
May 31, 2027
Study Completion Date
May 31, 2027
CHS-114
Solution for infusion
Toripalimab
Solution for infusion
5 Fluorouracil
Solution for infusion
Cisplatin
Solution for infusion
RECRUITING
Taipei Veterans General Hospital, Taipei
RECRUITING
National Cheng Kung University Hospital, Tainan City
RECRUITING
National Taiwan University Hospital, Taipei
RECRUITING
David H. Koch Center for Cancer Care at Memorial Sloan Kettering Cancer Center, New York
RECRUITING
University of Pittsburg Medical Center _UPMC Hillman Cancer Center, Pittsburgh
RECRUITING
Virginia Cancer Specialists, Fairfax
RECRUITING
Virginia Oncology Associates, Norfolk
RECRUITING
Prisma Health Cancer Institute, Greenville
RECRUITING
SCRI Oncology Partners, Nashville
RECRUITING
Taichung Veterans General Hospital, Taichung
RECRUITING
Ochsner Health, New Orleans
RECRUITING
Texas Oncology - Central South, Austin
RECRUITING
Huntsman Cancer Institute, University of Utah, Salt Lake City
RECRUITING
The University of Arizona Cancer Center, Tucson
RECRUITING
Christus St Vincent Regional Medical Center, Santa Fe
RECRUITING
City of Hope, Duarte
RECRUITING
China Medical University Hospital, Taichung
Lead Sponsor
Coherus Oncology, Inc.
INDUSTRY